Bionano Genomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2016
Revenue	37.47	36.12	27.8	17.98	8.5	10.13	Upgrade
Revenue Growth (YoY)	26.93%	29.90%	54.62%	111.47%	-16.06%	-15.59%	Upgrade
Cost of Revenue	27.15	26.55	21.86	14.11	5.73	6.77	Upgrade
Gross Profit	10.32	9.57	5.95	3.87	2.77	3.36	Upgrade
Selling, General & Admin	87.06	93.5	88.6	58.49	31.07	20.16	Upgrade
Research & Development	49.88	54.03	49.05	22.49	10.26	9.08	Upgrade
Other Operating Expenses	78.46	73.83	0.22	0.06	0.01	0	Upgrade
Operating Expenses	215.4	221.36	137.87	81.03	41.33	29.24	Upgrade
Operating Income	-205.08	-211.8	-131.92	-77.16	-38.56	-25.87	Upgrade
Interest Expense / Income	5.17	5.12	0.3	0.93	2.52	2.29	Upgrade
Other Expense / Income	16.53	15.52	-1.51	0.07	-	1.63	Upgrade
Pretax Income	-226.77	-232.43	-130.71	-78.15	-41.08	-29.79	Upgrade
Income Tax	0.02	0.06	1.88	-5.72	0.03	0.02	Upgrade
Net Income	-226.79	-232.49	-132.6	-72.44	-41.11	-29.82	Upgrade
Shares Outstanding (Basic)	53	34	29	28	10	1	Upgrade
Shares Outstanding (Diluted)	53	34	29	28	10	1	Upgrade
Shares Change	74.60%	18.08%	4.49%	165.50%	596.03%	111.64%	Upgrade
EPS (Basic)	-6.02	-6.81	-4.58	-2.60	-3.90	-19.90	Upgrade
EPS (Diluted)	-6.02	-6.81	-4.58	-2.60	-3.90	-19.90	Upgrade
Free Cash Flow	-122.26	-126.87	-127.99	-73.99	-38.31	-29.59	Upgrade
Free Cash Flow Per Share	-2.32	-3.71	-4.43	-2.67	-3.67	-19.76	Upgrade
Gross Margin	27.54%	26.49%	21.38%	21.54%	32.61%	33.18%	Upgrade
Operating Margin	-547.31%	-586.43%	-474.50%	-429.12%	-453.46%	-255.44%	Upgrade
Profit Margin	-605.26%	-643.74%	-476.93%	-402.84%	-483.43%	-294.34%	Upgrade
Free Cash Flow Margin	-326.28%	-351.29%	-460.36%	-411.51%	-450.59%	-292.12%	Upgrade
EBITDA	-207.91	-213.34	-120.1	-73.18	-37.08	-26.38	Upgrade
EBITDA Margin	-554.87%	-590.72%	-431.97%	-407.01%	-436.07%	-260.43%	Upgrade
Depreciation & Amortization	13.7	13.97	10.32	4.04	1.48	1.13	Upgrade
EBIT	-221.61	-227.31	-130.41	-77.23	-38.56	-27.51	Upgrade
EBIT Margin	-591.43%	-629.39%	-469.08%	-429.48%	-453.46%	-271.56%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).